DUPONT CAPITAL MANAGEMENT CORP - ORION BIOTECH OPPORTUNTES CO ownership

ORION BIOTECH OPPORTUNTES CO's ticker is ORIAW and the CUSIP is G6780C117. A total of 28 filers reported holding ORION BIOTECH OPPORTUNTES CO in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of ORION BIOTECH OPPORTUNTES CO
ValueSharesWeighting
Q1 2023$1,412
-56.8%
20,0000.0%0.00%
Q4 2022$3,268
-18.3%
20,0000.0%0.00%
Q3 2022$4,000
+33.3%
20,0000.0%0.00%
Q2 2022$3,000
-57.1%
20,0000.0%0.00%
Q1 2022$7,000
-63.2%
20,0000.0%0.00%
-100.0%
Q4 2021$19,000
+5.6%
20,0000.0%0.00%0.0%
Q3 2021$18,00020,0000.00%
Other shareholders
ORION BIOTECH OPPORTUNTES CO shareholders Q4 2021
NameSharesValueWeighting ↓
Empery Asset Management, LP 40,000$46,0000.10%
ANGELO GORDON & CO., L.P. 60,000$580,0000.05%
Radcliffe Capital Management, L.P. 80,000$780,0000.02%
Anson Funds Management LP 15,000$145,0000.01%
CANTOR FITZGERALD, L. P. 162,945$156,0000.01%
Arena Capital Advisors, LLC- CA 120,000$115,0000.01%
AQR Arbitrage LLC 40,000$387,0000.01%
MMCAP International Inc. SPC 160,000$154,0000.01%
Segantii Capital Management Ltd 30,000$290,0000.01%
Atalaya Capital Management LP 100,000$96,0000.01%
View complete list of ORION BIOTECH OPPORTUNTES CO shareholders